Abstract
To the Editor: The study by Allen et al. (May 22 issue) 1 showed that pasireotide reduced the risk of clinically relevant pancreatic fistula after either pancreaticoduodenectomy or distal pancreatectomy, whether or not the pancreatic duct was dilated. It would be useful to provide details regarding the presence of a dilated duct or a soft pancreatic texture in the pancreaticoduodenectomy group, because they were risk factors for clinically relevant pancreatic fistula after pancreaticoduodenectomy but not after distal pancreatec
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
